The Medical College of Wisconsin (MCW) has received a five year, $1.5 million grant from the National Institute of Health’s National Institute of Allergy and Infectious Diseases to study the pathogenesis of Pseudomonas aeruginosa, a bacterium that is intrinsically resistant to antimicrobials, and that is difficult to treat.
Dara Frank, PhD, professor of microbiology and molecular genetics and director of MCW’s Center for Infectious Disease Research, is the primary investigator of the grant. Jimmy Feix, PhD, professor of biophysics, is a co-investigator.
Pseudomonas aeruginosa has been linked to burn victims, immunocompromised patients, and individuals with cystic fibrosis. Colonization of organs such as the lungs or spread of the bacteria to the bloodstream, can result in a fatal infection. Toxins expressed by the bacteria make it particularly pathogenic.
In this study, Dr. Frank will study a toxin expressed by Pseudomonas aeruginosa called ExoU, which is correlated with poor outcomes in human infection. By studying ExoU and the system in which it is expressed, new insights about the pathogenic nature of the bacteria will be discovered, with the ultimate goal being to provide unique targets and biological tools to limit that pathogenicity—and improve outcomes in human infections.
Your link to the biggest stories in the suburbs delivered Thursday mornings.
Enter your e-mail address above and click "Sign Up Now!" to begin receiving your e-mail newsletter Get the Newsletter!
- Sky Zone Launches Fitness Challenge
- Ramirez Family Foundation pledges $1 million to improve healthcare quality and reduce costs
- Alicia, My Story
- 29th Annual Easter Egg Hunt
- NEWCASTLE PLACE TO HOST MEMORIES IN THE MAKING® ART SHOWCASE
- Holy Week Celebration Services at Trinity UCC
- Prata Duo To Present Free Concert
- MCW researchers to study medication to treat traumatic brain injury
- Two Comedy Shows benefit local military charities
- 15 Companies Join Milwaukee/NARI Home Improvement Council